.Pharmacolibrary.Drugs.N_NervousSystem.N07X_OtherNervousSystemDrugs.N07XX13_Valbenazine.Valbenazine .Pharmacolibrary.Drugs.N_NervousSystem.N07X_OtherNervousSystemDrugs.N07XX13_Valbenazine.Valbenazine| name: | Valbenazine | |
| ATC code: | N07XX13 | route: | oral |
| compartments: | 1 | |
| dosage: | 80 | mg |
| volume of distribution: | 92 | L |
| clearance: | 7.2 | L/h |
| other parameters in model implementation | ||
Valbenazine is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor used primarily for the treatment of tardive dyskinesia in adults. It is FDA-approved and serves to reduce the severity of abnormal, involuntary movements associated with tardive dyskinesia.
Pharmacokinetic parameters reported in adults following single and multiple oral doses; subjects were generally healthy or adult patients with tardive dyskinesia.